BICARA THERAPEUTICS INC (BCAX) Stock Analyst Ratings
NASDAQ:BCAX - Nasdaq - US0554771032 - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to BCAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 40.55. This target is 144.98% above the current price.
BCAX was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about BCAX.
In the previous month the buy percentage consensus was at a similar level.
BCAX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-02-06 | Wedbush | Initiate | Outperform |
| 2025-01-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-06 | HC Wainwright & Co. | Initiate | Buy |
| 2024-10-08 | TD Cowen | Initiate | Buy |
| 2024-10-08 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-10-08 | Stifel | Initiate | Buy |
| 2024-10-08 | Morgan Stanley | Initiate | Overweight |